Literature DB >> 22179684

Cardiometabolic risk in Chinese women with prior gestational diabetes: a 15-year follow-up study.

Wing-Hung Tam1, Ronald Ching-Wan Ma, Xilin Yang, Gary Tin-Choi Ko, Terence Tzu-Hsi Lao, Michael Ho-Ming Chan, Christopher Wai-Kei Lam, Clive Stewart Cockram, Juliana Chung-Ngor Chan.   

Abstract

AIMS: The progression to type 2 diabetes mellitus (DM) and other long-term cardiometabolic risks in Chinese women with prior history of gestational diabetes (GD) was studied at 15 years postpartum.
METHODS: 139 Chinese women (45 with GD and 94 with normal glucose tolerance (NGT) at the index pregnancy) who had their insulin sensitivity and β-cell functions examined at 8 years postpartum were again followed up at 15 years for the investigation of the rate of type 2 DM, hypertension and metabolic syndrome.
RESULTS: Women with prior history of GD had a significantly higher rate of hypertension (35.6% vs. 16.0%, p = 0.01), type 2 DM (24.4% vs. 5.3%, p < 0.001) and impaired glucose regulation (26.6% vs. 14.9%, p < 0.001) than women with NGT during the index pregnancy. The Matsuda insulin sensitivity index and the quantitative insulin sensitivity check index at 8 years postpartum were independent predictors of both DM and metabolic syndrome at 15 years postpartum.
CONCLUSIONS: The conversion rate of type 2 DM increased at an average rate of 1.6% per year after a pregnancy affected by GD. Insulin resistance at 8 years postpartum could refine a future diabetic risk in women with prior history of GD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22179684     DOI: 10.1159/000329339

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  Gestational Diabetes Mellitus Among Asians - A Systematic Review From a Population Health Perspective.

Authors:  Ling-Jun Li; Lihua Huang; Deirdre K Tobias; Cuilin Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

2.  Association between metabolic syndrome and gestational diabetes mellitus in women and their children: a systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra S Lassi; Anna Ali; Margaret A Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Endocrine       Date:  2020-09-15       Impact factor: 3.633

Review 3.  Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis.

Authors:  Yuhong Xu; Shutong Shen; Lizhou Sun; Haiwei Yang; Bai Jin; Xiaohui Cao
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

4.  The risk of metabolic syndrome after gestational diabetes mellitus - a hospital-based cohort study.

Authors:  Tiina Vilmi-Kerälä; Outi Palomäki; Merja Vainio; Jukka Uotila; Ari Palomäki
Journal:  Diabetol Metab Syndr       Date:  2015-05-12       Impact factor: 3.320

5.  Randomized trial examining effectiveness of lifestyle intervention in reducing gestational diabetes in high risk Chinese pregnant women in Hong Kong.

Authors:  Ruth Suk-Mei Chan; Wing-Hung Tam; Ivan Chak-Hang Ho; Macy Wai-Chi Kwan; Liz Sin Li; Mandy Man-Mei Sea; Jean Woo
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

6.  Long-term maternal cardiometabolic outcomes 22 years after gestational diabetes mellitus.

Authors:  Greg E Tutino; Claudia Ht Tam; Riza Ozaki; Lai Yuk Yuen; Wing Yee So; Michael Hm Chan; Gary Tc Ko; Xilin Yang; Juliana Cn Chan; Wing Hung Tam; Ronald Cw Ma
Journal:  J Diabetes Investig       Date:  2020-02-20       Impact factor: 4.232

Review 7.  Risk of type 2 diabetes mellitus after gestational diabetes mellitus: A systematic review & meta-analysis.

Authors:  Huaxuan You; Juan Hu; Ying Liu; Biru Luo; Anjiang Lei
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

8.  Progression to type 2 diabetes mellitus and associated risk factors after hyperglycemia first detected in pregnancy: A cross-sectional study in Cape Town, South Africa.

Authors:  Tawanda Chivese; Shane A Norris; Naomi S Levitt
Journal:  PLoS Med       Date:  2019-09-09       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.